The Data Developers — Life Sciences Intelligence
IP & Patent context

Regulatory exclusivity shield context

Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.

All FDA exclusivity codes (NCE, ODE, PED, NDF, etc.) with expiry dates. Exclusivity shield analysis for IRA eligibility assessment.

8K+ exclusivity entries Monthly Updated 2026-09-01

Overview

Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.

All FDA exclusivity codes (NCE, ODE, PED, NDF, etc.) with expiry dates. Exclusivity shield analysis for IRA eligibility assessment.

Build patent cliff and loss-of-exclusivity timelines using normalized patent, exclusivity, and approval identifiers.

Compare FDA-listed patents with USPTO metadata, assignee networks, and forward citation context.

Separate substance, product, and method-of-use protection when modeling generic or biosimilar entry.

Join IP records to revenue, labels, clinical stage, and target biology through the drug identity spine.

Source authority

FDA Orange Book Exclusivity Files

Freshness

Last refreshed 2026-09-01

Monthly

Coverage

8K+ exclusivity entries

2 delivery tables